Beyond Antibiotics: How Natural Feed Additives & Outdoor Access Can Boost Pig Health
"Discover the potential of mannan oligosaccharides (Bio-Mos) and outdoor housing to improve pig growth and well-being, offering a promising alternative to traditional antibiotic use in livestock farming."
In an era where concerns about antibiotic resistance are escalating, the livestock industry is under increasing pressure to find alternative strategies for promoting animal health and growth. Traditional reliance on antibiotics as growth promoters is being questioned, leading researchers and farmers to explore innovative solutions that prioritize both animal welfare and sustainable practices. This article delves into a compelling study that investigates the potential of mannan oligosaccharides (Bio-Mos) and outdoor access housing systems to enhance pig health, growth, and overall carcass composition.
The study, conducted by researchers at The Ohio State University, examines the effectiveness of Bio-Mos, a prebiotic, in comparison to subtherapeutic antibiotic treatments and conventional housing systems. The core objective is to identify viable alternatives to antibiotics that not only maintain but also improve pig performance and health. This research is particularly relevant as legislative bans on antibiotic use in livestock gain traction globally, pushing the industry towards more sustainable and health-conscious farming methods.
This comprehensive analysis not only sheds light on the immediate benefits of these alternative approaches but also addresses broader implications for the future of swine farming. By understanding the interplay between natural feed additives, housing conditions, and pig physiology, we can pave the way for more responsible and effective strategies in livestock management.
Responsible Antibiotic Use and Its Limits
Antibiotics may be needed to treat illness in pigs, and the Pork Checkoff describes responsible use as giving only what is necessary for animal health, food safety, and the environment. However, restrictive, barren housing and painful or stressful management practices can predispose high-performance pigs in intensive systems to disease, making antibiotics part of the infrastructure that sustains health and production. Research on alternatives notes that combinations of biologics and immunomodulatory agents may help address these limitations, but the effects of antimicrobial growth promoters and their alternatives on intestinal microbiota, intestinal health, and growth remain diverse and inconsistent.
Unpacking the Science: Bio-Mos and Outdoor Housing
The research design was structured as a 3 × 2 factorial experiment, involving 360 pigs from a Landrace breeding female population. The pigs were divided into groups receiving one of three dietary treatments: a control diet, a diet supplemented with Bio-Mos, or a diet including a subtherapeutic antibiotic (tetracycline). The Bio-Mos was administered at varying inclusion rates across different growth phases, ensuring a targeted approach to nutritional support.
- Bio-Mos (BM): A prebiotic that supports gut health.
- Antibiotic (AB): Tetracycline, included at 0.0055% in all dietary phases.
- Control (CON): A standard diet without additives.
- Indoor (IN): Conventional, indoor facility with limited space per pig.
- Outdoor Access (OUT): More space per pig with bedded concrete and outdoor area.
Emerging Feed-Additive Evidence
A study of weaned pigs found that combinations of starch, non-starch polysaccharides, and mannan-oligosaccharide affected gain-to-feed ratio, diarrhea incidence, nutrient digestibility, microbial communities, and short-chain fatty acid concentrations. In a separate intestinal-cell model, adding 150 ppm of a proprietary blend of yeast cell wall, short-chain fatty acids, and zinc proteinate produced greater cell densities than the control and 150 ppm butyrate at 24 hours, alongside greater protein and glucose utilisation. Other research has examined how immune stimulation by porcine reproductive and respiratory syndrome virus alters plasma amino acid flux and dietary nitrogen utilization in starter pigs, while a 2025 Dutch study investigated diseases associated with therapeutic antimicrobial use in weaners and sows with suckling piglets.
Why Antibiotic Reduction Is Difficult
Reducing antibiotic use cannot be separated from the housing and management conditions that influence pig health. Reviews report that restrictive, barren housing and practices causing pain and stress predispose high-performance pigs in intensive systems to disease, with antibiotics then functioning as part of the infrastructure supporting health and high production. Public-health and social research on antimicrobial resistance has also focused heavily on antibiotic use as a practice, underscoring that the debate extends beyond farm productivity.
Limits of the Available Comparison
The listed comparative study concerns 240 day-old commercial broilers, not pigs. It compared floor and cage rearing across three housing zones in an environmentally controlled house during winter. Because the study population and species differ from the subject of this article, its details do not establish a direct comparison of pig housing systems or outdoor access.
Moving Forward: Towards Sustainable Swine Farming
The insights gained from this study offer a promising outlook for the future of swine farming. By integrating natural feed additives like Bio-Mos and optimizing housing conditions to include outdoor access, the industry can move towards more sustainable and responsible practices. These changes can not only reduce our reliance on antibiotics but also promote better animal welfare and improve overall production efficiency. As consumer awareness and regulatory pressures continue to grow, adopting these innovative approaches will be crucial for ensuring the long-term viability and ethical integrity of the swine farming industry.